Nalaganje...
First-dose idarubicin cardiomyopathy: a case of new heart failure after induction chemotherapy for acute myeloid leukaemia
Anthracyclines are an effective chemotherapy agent. However, very few cases of idarubicin-induced cardiomyopathy exist. Herein, we describe a case of first-dose idarubicin-related acute heart failure in a woman with a history of myelodysplastic syndrome converted to acute myeloid leukaemia.
Shranjeno v:
| izdano v: | BMJ Case Rep |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BMJ Publishing Group
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6536188/ https://ncbi.nlm.nih.gov/pubmed/31101747 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2018-228149 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|